Leadership Team

Dr. Anu Dambalkar, MBBS,Diploma in Pharmacovigilance
Senior Drug Safety Physician

Senior Drug Safety Physician with over 4 years of pharmacovigilance and 3 years of clinical experience.
Pharmacovigilance experience

  • Experienced in the preparation of aggregate reports including but not limited to:
    • Periodic Benefit Risk Evaluation Reports (PBRERs)/ Periodic Safety Update Reports (PSURs)
    • Periodic Adverse Drug Experience Reports (PADERs)
    • Addendum to Clinical Overview (ACOs)
    • Health Hazard Evaluations (HHEs)
  • Experienced in Case Analysis for Ad Hoc reports and Surveillance Analysis of Non Spontaneous Safety Data for PharmacoVigilance (SNAP)
  • Experienced in conducting medical review of PBRERs/PSURs, PADERs, HHEs, Ad Hoc Reports, SNAP and Safety Management Team (SMT) Slides which includes checking the case for overall medical cohesiveness, checking the expectedness of adverse events, adding company causality and company comments
  • Trained in Monthly Signal Reports and Drug Abuse Report for Food and Drug Administration (FDA)
  • Maintaining a knowledge of the AE safety profile of assigned drugs, Reference Safety Information documents, aggregate reporting conventions and guidelines, clients’ procedures and international drug safety regulations including
    • ICH guidelines on safety and efficacy
    • Volume 9a
    • New PV legislation
    • FDA guidelines
    • CIOMS
  • Maintaining an awareness of global regulatory reporting obligations and organizing workload to ensure compliance with regulatory timelines
  • Experienced in conducting medical review of PBRERs/PSURs, which includes checking the case for overall medical cohesiveness, checking the expectedness of adverse events, adding company causality and company comments
  • Trained in MedDRA coding in accordance with “MedDRA Term Selection: Points to Consider”

Dr. Devesh Kumar
Director - Clinical Operations

Dr. Devesh Kumar is a seasoned clinical research professional and has successfully launched various organizations for different industries.
In his previous avatar, he worked closely with the higher management of Fortis and Max Group companies and helped define the strategy of the company. He drove business modeling, project management analytic and specialty planning.
He is Meticulous, goal-oriented professional with hands on real time experience of End to End Clinical Trial Project Management, Data Management and Business Development for Clinical Trials
A keen strategist with the ability to understand and articulate key opportunities in ever changing research industry. He has great proficiency in planning, organizing, executing & training subordinates on protocol based management and conduct of clinical trials
He has worked on various designations like CRA, Lead CRA, Assistant project Manager, project Manager and head operations. Worked on more than 100 global and domestic trials and is an effective communicator with excellent relationship management skills, problem solving and organizational abilities.
He is a medical graduate from Lucknow and posses post graduation diploma in clinical research and certification on FDA IND and NDA approval process from FDA smart. His immense vast experience of more than a decade in industry brings a variety to Thinki for all research processes and trials.

Mr.Joseph Mathew
Senior Manager- Pharmacovigilance Training and Consulting

Joseph comes with a varied experience in Pharmacovigilance & IT. He is a Subject matter Expert on Safety Databases and on writing White Papers, his recently published white paper was on Role of technology in Vaccine Safety. He is currently the Head of Pharmacovigilance operations at Think I.
His Key responsibility areas includes Developing module on pharmacovigilance, Delivering end to end pharmacovigilance training and participating in business development activities and medical writing services.
Prior to his role in Think I, he was supporting Pharmacovigilance activities for Baxter Inc. by doing Intake of cases for APAC team which included reports from Taiwan, Korea, Vietnam, Hong Kong, Indonesia and India and regulatory submissions for Korea via KAERS (Korea Adverse Event Reporting System) by working closely with Local Pharmacovigilance officers of each country
Prior to which his work at Pfizer Inc. involved processing of Solicited /Spontaneous case reports using Pharmacovigilance Safety Databases like ARGUS, ARISg where he was Awarded Top Pfizer Safety Contact Centre Officer.
He has also managed various other Pharmacovigilance Safety databases Like, IRMS (case management tools) PFIDO, PFITRACK, CITRIX, Safety Easy by AB Cube.
At Pfizer he also got the opportunity to be the part of the Pilot batch process in providing assistance to Pfizer’s associate partner My Meds and Me by conducting time-motion studies and Beta testing on REPORTUM
Joseph is a registered pharmacist with Delhi Pharmacy Council. He also has an experience in Hospital Pharmacy from All India Institute of Medical Sciences [A.I.I.M.S] New Delhi along with certifications in Entrepreneurship, Intellectual proprietary rights, Good Clinical practices, Nutrition and Medical Reporting.

Dr. Veepra
Head - Operations & Training

Dr. Veepra, is a registered dental graduate from Lucknow. She has completed her Master’s degree from Lucknow in Community Medicine & Public Health, and is a clinical Research Professional with 7 years of experience in both national and International clinical trials. She possesses excellent communication skills along with clarity of fundamentals with perseverance to succeed.
She is a part of Cliniminds as the Head - Operations & Training (Institute of Health Sciences Training & Management) since July 2015.
The key responsibility areas includes management of Academics at all Cliniminds centre (India & Global), developing and updating training modules and content for Clinical Research and delivering training programs.
Prior to her role in Academics, she has worked for global clinical trials for pharmaceutical giants like AstraZeneca, GSK, Sanofi Aventis, Zydus etc. She also has good working knowledge of ICH-GCP, Sch-Y, USFDA, and various regulatory requirements in clinical research. Global clinical trial experience & good understanding on all Phases.
She has successfully cleared many audits and inspection by sponsors and regulatory bodies like DCGI.
Strong Project & People Management experience. Strong believe in creating environment for the growth of the team members by hard work and professional commitment & passion for success.
She has a broad background in clinical trial management of phase III and IV drug trials, managing projects & study teams right from start-up to close-out in various specialization in following therapeutic indications: - Oncology, Cardiology, Endocrinology, Ophthalmology, Pulmonology, Dermatology, Oncology, Surgery (done trials on abdominal infections, Allergic rhinitis, vernal keratoconjuctivitis, metastatic breast cancer, head and neck cancer, UTI infection to name a few). She is specialized in on-site data management and collection, patient recruitment activities.
Meeting client expectations on projects has always been priority agenda of her work during these last years.
She brings with her good management and administrative skills with experience as an outsource auditor, along with a book on Glossary of Clinical Research and Ethics in Clinical Research.

Charles Anthony Suarez
Clinical Research & Pharmacovigilance Professional

Charles Anthony Suarez, RPh is a registered pharmacist and an experience clinical research and pharmacovigilance professional. He finished BS Pharmacy from the University of Santo Tomas. He is currently finishing Postgraduate Diploma in International Health (leading to Masters of International Health) at the University of the Philippines.
He has around 5 years of managerial and mid-level career experience centered on Clinical Research and Pharmacovigilance activities which are not limited to the following: Feasibility, Start-up (Including Contract and Budget Negotiation, Regulatory Submissions), Site Selection, Site Initiation, Site Monitoring, Site Close-out, Site Audit, SOP Writing, Pharmacovigilance (Line Management, Case Receipt, Triage, Case Processing, Scientific review, Quality Control, Regulatory Submissions, Database Management, Sponsor and Site Communication, SOP Writing), Patient Recruitment & Retention Services and Business Development. He has therapeutic experiences in Cardiology, Dermatology, Endocrinology (Diabetes), Immunology (Vaccines), Neurology, Nutritionals, Oncology, Ophthalmology, and Psychiatry which covers Phase I to Phase IV trials.
He recently also helped out in a commission to set up a research facility on stem cell and consultant to various clinical research and training program to start-up sites and CROs.

Dr. Namrata Tiwari
Consultant, Safety and Pharmacovigilance Operations , Training and compliance

She is associated with over 8 years in the pharmaceutical industry and worked in companies like Ranbaxy and Merck (MSD), where she was responsible for ICSRs, PSURs, SOPs, causality assessment, safety system validation and maintenance, ,Signal Detection ,safety database management, Safety Data Exchange Agreements, risk management plans and compliance monitoring. She also headed Pharmacovigilance operations thereby gaining experience in premarketing and post marketing safety reporting. Also fortunate to work on Eudravigilance project and was EMEA accreditated QC trained for ICSR.

In Thinki, she heads the Pharmacovigilance Unit, playing a key decisive role in establishing the unit and guiding team members for successful inspections by clients and regulatory authorities. She is responsible for global quality and compliance.

Dr. Raj Phadtare
Drug Safety Consultant

  • Experienced Drug Safety professional with over 12 years of experienceat various levels in small to mid-sized Bio-pharmaceutical companies in the USA
  • Responsible for all Pharmacovigilance activities for marketed and investigational drug products
  • Authored and ensured that individual SUSAR reports and aggregate safety reports (PSURs,DSURs) for FDA and EU regulatory authorities were completed and submitted in accordance with regulatory requirements
  • Worked on a CCSIs of marketed products
  • Reviewed Protocols and Investigator Brochures
  • Chaired the Medical Safety Review committee which is established to monitor the safety of the products in clinical development and/or in the Market. Activities include but are not limited to identification of potential product specific safety signals/trends, AE case series review, review of scientific literature, review and updates to product labels
  • Created and maintained Pharmacovigilance and Safety Data Exchange Agreements; served as company/partner liaison; ensured corporate and partner compliance with internal and global regulatory requirements
  • Participated in the development of and provided oversight for the REMS program for a CNS product
  • Participated in successful FDA audits for Pharmacovigilance
  • Developed SOPs and Work Practice guidelines for Drug Safety department throughout the life cycle of the product (pre and post marketing) and centralized Drug Safety functions at various companies
  • Responsible for handling safety related activities including receipt, triage, processing, reporting and dissemination of Adverse Events and Serious Adverse Events (SAE) from spontaneous sources and SAE’s from company sponsored clinical trials
  • Supported case processing activities by performing medical review of the cases and assessing the expedited reporting
  • Managed the activities of Drug Safety vendor for AE case processing

Mr. Pinku Hooda
Head, Clinical Data Management

A high-performing operations-management executive with expertise in all aspects of Clinical Data Management and SAS for Phase I to IV and BA/BE studies for a wide array of therapeutic areas, Mr. Hooda has over 10 years of experience working in pharmaceutical companies and CROs with a strong commitment to this important field of research. He can effectively interface and collaborate between Data Management, Biostatistics and Pharmacovigilance teams to ensure high quality data and on-time completion of complex, large-scale projects. His chief expertise lies in leading and training project teams as he possesses strong communication, interpersonal, problem solving, planning, and organizing skills.

Dr. Subodh Bhardwaj
Vice President Scientific & Medical Affairs

An innovative Medical Doctor with Post Graduation in Pharmacology and more than 30+ years of experience in Clinical Medicine, Clinical Research, Pharmaco-vigilance and Regulatory affairs. Varied experience of 20 years in the Bio- Pharmaceutical Industry with reputed companies like Serum Institute Of India, Sanofi Pasteur, Aventis, Shanta Biotechnics, Serono, MBL, Crucell and interactions with WHO, Ministry of Health, DCGI, DBT, ICMR, IMA, IAP, OPPI, APACHE, APCRI.

Planned and completed over 100 clinical trials ranging from Pre-clinical, Phase1-4 and pharmaco-epidemiological studies. Possess exemplary skills in Regulatory affairs in India and fully updated on EU, US regulations. Have worked in Pharmaco-vigilance since 30 years with some interesting publications. Excellent Medical writing skills and Editorial experience with Indian Journal of Pharmacology. Over 60 publications in National &International Journals. Have actively published several product monographs, PILs and publications for public interest. Have been MPharm & Phd guide at University of Pune. Excellent Public speaking and Analytical skills. Widely travelled and have done clinical trials in 10 countries across the world. Proven track record in the health sciences field.

Dr. Sanjukta Bhattacharya
Clinical Research & Medical Writing Expert

PhD is a pharma professional with 14 years of industry experience including 9 years in clinical research and 5 years in project management of NCE preclinical & clinical development. She is skilled in conducting ICH-GCP and Schedule Y of Indian Drugs and Cosmetics Act governing clinical trials. She has extensive experience in managing multicentric trials across India, Asian and African countries. She has worked in Ranbaxy Research Laboratories, Pharmacia (Pfizer) and LG Life Sciences in multicultural environment.

She has also been a visiting faculty at Jamia Hamdard University, Delhi where she has taken lectures for post-graduate students of clinical research.

At Ranbaxy, she lead the clinical development of Synriam, an antimalarial – India’s first new drug which was launched in 2012. She has received various awards for demonstrating commitment and contribution in clinical research. She was recently felicitated by the former President of India, Dr. A.P.J. Kalam for exceptional contribution in development of Synriam.


Dr. Pandey is qualified medical doctor with 11 years of experience in managing Healthcare, Life sciences, Pharmacovigilance process transition, operations, client interaction.

Dr. Pandey has extensive experience with Accenture as Deputy Manager and iGATE as Team Manager – Pharmacovigilance Operations. Worked as Domain expert/ SME –pharmacovigilance with Pfizer Inc. Her experience and skills includes :

  • Expertise in handling client facing situations.
  • Strong Project management and operations management skills.
  • Strong knowledge in maintaining quality systems to ensure the quality of processes and deliverables of both projects and services meet the expectations as per regulatory requirements.
  • Validation lead for multiple projects.
  • Argus implementation boot camp training conducted by Oracle.
  • Trained in Argus 7.0 safety application.
  • Knowledgeable in processes and tools pertaining to Pharmacovigilance (Argus, ArisG, Ag Exchange and CARES) based on COTS life cycle.
  • Knowledgeable in various regulatory guidelines like ICH guidelines, Good Clinical Practices, Good Documentation Practices and Code of Federal Regulations, Volume 9A etc.
  • Business Process development - Developed SOPs and SOW for the process.
  • Functional testing (OQ/PQ) for ArisG safety suite.
  • Post execution QA lead for testing of PQ/OQ scripts of ArisG safety application and Ag Exchange suite.
  • Extensive exposure in managing drug safety operations in leading IT companies.
  • An effective communicator & competent subject matter expert with honed analytical, operational & organizational abilities.